发明名称 SUSTAINED-RELEASE FORMULATIONS FOR TREATING CNS-MEDIATED DISORDERS.
摘要 <p>Sustained-release compositions for delivering therapeutic concentrations of isovaleramide, isovaleric acid, and certain structurally related compounds are provided for the treatment for a variety of pathological conditions, including epilepsy and spasticity, which are ameliorated by effecting a modulation of CNS activity. The ability of the compositions to sustain relatively constant levels of the drug at a therapeutic dose in the serum for extended periods of time enables a once or twice daily administration schedule.</p>
申请公布号 MXPA02003976(A) 申请公布日期 2003.09.25
申请号 MX2002PA03976 申请日期 2000.10.19
申请人 NPS PHARMACEUTICALS, INC. 发明人 LIAN G. RAJEWSKI
分类号 A61K9/16;A61K9/20;A61K9/22;A61K9/28;A61K9/36;A61K9/50;A61K9/52;A61K31/16;A61K31/18;A61K31/19;A61K31/22;A61K31/255;A61K31/27;A61K47/30;A61K47/36;A61K47/38;A61P15/08;A61P17/02;A61P25/00;A61P25/02;A61P25/04;A61P25/06;A61P25/08;A61P25/18;A61P25/20;A61P25/22;A61P25/30;A61P25/32;A61P25/34;(IPC1-7):A61K9/00 主分类号 A61K9/16
代理机构 代理人
主权项
地址